Search results
Author(s):
Dan Wichterle
Added:
3 years ago
Myocardial infarction (MI) is associated with acute risk of early malignant arrhythmias that can be easily treated during in-hospital intensive care by defibrillation, adjuvant antiarrhythmic therapy or even catheter ablation in resistant cases. Indeed, such management resulted in substantial improvement in MI survival rate. Despite the implementation of primary percutaneous coronary…
View more
Author(s):
Nazli Okumus
,
Jeffrey L Carson
Added:
5 months ago
AHA 2023 — Investigator, Dr Jeffrey Carson (Rutgers University, US) joined Dr Nazli Okumus, CardioNerds Ambassador to discuss findings from the MINT trial (NCT02981407).The aim of this randomised, parallel assignment trial (Rutgers) is to compare liberal and restrictive red blood cell transfusion strategies in patients who have had an acute myocardial infarction (AMI) and are anemic…
View more
Author(s):
Nagara Tamaki
,
Yuji Kuge
,
Keiichiro Yoshinaga
Added:
3 years ago
The heart requires a high rate of oxygen uptake to maintain mechanical function in order to provide sufficient energy to balance the requirement of the mechanical function. Oxygen consumption increases in almost direct ratio to the increased workload; when the oxygen supply is inadequate for the demand, reversible or irreversible metabolic changes may occur. Such an imbalance is most often…
View more
Author(s):
Alda Huqi
,
Giacinta Guarini
,
Doralisa Morrone
,
et al
Added:
3 years ago
Myocardial revascularisation in patients with stable chronic angina is performed with the aim of reducing cardiovascular death, reducing myocardial infarction (MI) and relieving angina symptoms. However, contrary to expectations, modern therapy with percutaneous coronary intervention (PCI) has not had a significant impact on hard outcomes.1–5 Indeed, as also summarised in a recently published…
View more
Author(s):
Nawwar Al-Attar
,
Patrick Nataf
Added:
3 years ago
Introduction
The internal thoracic artery (ITA) demonstrates superior long-term clinical results after coronary artery bypass grafting (CABG) compared with saphenous vein grafts with 85-95% freedom from significant stenosis at seven to 10 years.1-4 Moreover, the ITA outperforms other arterial grafts, namely the radial and gastroepiploic arteries, and is now undeniably the conduit of choice for…
View more
Author(s):
Lee Chang
,
Robert Yeh
Added:
3 years ago
Cardiogenic shock is the leading cause of death in patients with acute ST-elevation myocardial infarction (STEMI). Characterised by a state of low cardiac output leading to end-organ hypoperfusion, cardiogenic shock complicates approximately 5–8 % of STEMIs and is associated with a mortality rate approaching 50 percent.1–3 Prompt recognition and therapeutic intervention for cardiogenic shock due…
View more
Author(s):
Mai Tone Lønnebakken
,
Eva Gerdts
Added:
3 years ago
Coronary artery disease (CAD) remains a diagnostic challenge, even though there are several diagnostic techniques available for the detection of ischaemia – assessed either as function or perfusion abnormalities or directly by demonstrating anatomical coronary stenoses.1 An overview of different non-invasive modalities used in the diagnosis of myocardial ischaemia and their average sensitivity…
View more
Author(s):
Gustav Steinhoff
Added:
3 years ago
Cell therapy for myocardial regeneration is an exciting new field of medical research that has the potential to revolutionise cardiovascular medicine. Despite significant improvements in emergency treatment, myocardial infarction (MI) leads to a net loss of contractile tissue in many patients with coronary artery disease (CAD). Often, this is the beginning of a downward spiral towards congestive…
View more
Author(s):
Gustav Steinhoff
Added:
3 years ago
Cell therapy for myocardial regeneration is an exciting new field of medical research that has the potential to revolutionize cardiovascular medicine. Despite significant improvements in emergency treatment, myocardial infarction leads to a net loss of contractile tissue in many patients with coronary artery disease. Often, this is the beginning of a downward spiral towards congestive heart…
View more
Author(s):
Harvey D White
,
Derek P Chew
Added:
3 years ago
The cumulative evidence base informing almost every aspect of myocardial infarction acute coronary syndrome (ACS) care is expansive and has been associated with a decline in the rate of mortality. Within the context of current-era clinical trials of ST-segment-elevation myocardial infarction, 30-day mortality rates of 4–5% have now been reported for high-risk individuals,1,2 with similar rates…
View more